Nav: Home

Zika vaccines protect mice from infection

June 28, 2016

A single dose of either of two experimental Zika vaccines fully protected mice challenged with Zika virus four or eight weeks after receiving the inoculations. The research, conducted by investigators supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, suggests that similar vaccines for people could be similarly protective.

Zika virus infection during pregnancy can result in microcephaly and other serious birth defects in the fetus, making the development of a safe and effective vaccine a global health priority. Scientists led by Dan H. Barouch, M.D., Ph.D., at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School, as well as the Ragon Institute of MGH, MIT and Harvard, developed one of the Zika vaccines. Called a DNA vaccine, it contains genetic snippets from a Zika virus strain that circulated recently in Brazil to elicit immune responses. The second vaccine is made from a purified, inactivated Zika virus that recently circulated in Puerto Rico. It was developed by Stephen J. Thomas, M.D, Kenneth H. Eckels, Ph.D., Nelson L. Michael, M.D., Ph.D., and colleagues at Walter Reed Army Institute of Research, Silver Spring, Maryland.

In a first set of mouse experiments, the BIDMC investigators established that virus-specific antibodies were induced by the DNA vaccine. Next, the teams injected either of the two experimental vaccines into additional groups of mice. Four weeks later, mice that had received the DNA vaccine were exposed to the Brazilian strain of Zika virus known to cause fetal birth defects in mice analogous to those seen following fetal Zika infection in humans. No virus replication was detected in any of the vaccinated mice. Other mice receiving the DNA vaccine were exposed to virus eight weeks later. They, too, were protected from infection. The inactivated virus vaccine also protected mice from Zika infection. Moreover, the Zika-specific antibody levels detected in the mice appeared to correlate with protection against infection.

The researchers note that both DNA and inactivated virus vaccines have been developed to prevent infection by West Nile, dengue and tick-borne encephalitis viruses, all of which are in the same virus family as Zika. "Taken together, our findings provide substantial optimism that the development of a safe and effective Zika vaccine for humans will likely be feasible," they write.
-end-
ARTICLE:

RA Larocca et al. Vaccine Protection against Zika Virus from Brazil. Nature DOI: 10.1038/nature18952 (2016).

WHO:

NIAID Director Anthony S. Fauci, M.D., and Cristina Cassetti, Ph.D., program director in NIAID's Division of Microbiology and Infectious Disease, are available to comment on this research.

CONTACT:

To schedule interviews, please contact Anne A. Oplinger, (301) 402-1663, aoplinger@niaid.nih.gov.

This research was funded, in part, by the following NIAID grants: AI095985, AI096040, AI00663 and AI124377.


NIAID conducts and supports research--at NIH, throughout the United States, and worldwide--to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.NIH...Turning Discovery Into Health®

NIH/National Institute of Allergy and Infectious Diseases

Related Dna Articles:

Penn State DNA ladders: Inexpensive molecular rulers for DNA research
New license-free tools will allow researchers to estimate the size of DNA fragments for a fraction of the cost of currently available methods.
It is easier for a DNA knot...
How can long DNA filaments, which have convoluted and highly knotted structure, manage to pass through the tiny pores of biological systems?
How do metals interact with DNA?
Since a couple of decades, metal-containing drugs have been successfully used to fight against certain types of cancer.
Electrons use DNA like a wire for signaling DNA replication
A Caltech-led study has shown that the electrical wire-like behavior of DNA is involved in the molecule's replication.
Switched-on DNA
DNA, the stuff of life, may very well also pack quite the jolt for engineers trying to advance the development of tiny, low-cost electronic devices.
Researchers are first to see DNA 'blink'
Northwestern University biomedical engineers have developed imaging technology that is the first to see DNA 'blink,' or fluoresce.
Finding our way around DNA
A Salk team developed a tool that maps functional areas of the genome to better understand disease.
A 'strand' of DNA as never before
In a carefully designed polymer, researchers at the Institute of Physical Chemistry of the Polish Academy of Sciences have imprinted a sequence of a single strand of DNA.
Doubling down on DNA
The African clawed frog X. laevis genome contains two full sets of chromosomes from two extinct ancestors.
'Poring over' DNA
Church's team at Harvard's Wyss Institute for Biologically Inspired Engineering and the Harvard Medical School developed a new electronic DNA sequencing platform based on biologically engineered nanopores that could help overcome present limitations.

Related Dna Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...